Orthofix Medical (OFIX) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Orthofix Medical | 375.38 Mn | 254.51 Mn | 139.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,653.00 |
| Dec 31, 2025 | 133.00 |
| Sep 30, 2025 | 959.00 |
| Jun 30, 2025 | 2,951.00 |
| Mar 31, 2025 | -5,112.00 |
| Dec 31, 2024 | -13,451.00 |
| Sep 30, 2024 | 821.00 |
| Jun 30, 2024 | 1,495.00 |
| Mar 31, 2024 | -2,093.00 |
| Dec 31, 2023 | -15,698.00 |
| Sep 30, 2023 | -1,558.00 |
| Jun 30, 2023 | 1,099.00 |
| Mar 31, 2023 | -5,123.00 |
| Dec 31, 2022 | 12,262.00 |
| Sep 30, 2022 | 817.00 |
| Jun 30, 2022 | -517.00 |
| Mar 31, 2022 | 861.00 |
| Dec 31, 2021 | -2,566.00 |
| Sep 30, 2021 | -1,616.00 |
| Jun 30, 2021 | 2,004.00 |
| Mar 31, 2021 | -1,162.00 |
| Dec 31, 2020 | 1,500.00 |
| Sep 30, 2020 | 961.00 |
| Jun 30, 2020 | -1,975.00 |
| Mar 31, 2020 | 3,686.00 |
| Dec 31, 2019 | 1,638.00 |
| Sep 30, 2019 | -1,850.00 |
| Jun 30, 2019 | -41.00 |
| Mar 31, 2019 | 283.00 |
| Dec 31, 2018 | 2,587.00 |
| Sep 30, 2018 | 1,533.00 |
| Jun 30, 2018 | 473.00 |
| Mar 31, 2018 | 1,350.00 |
| Dec 31, 2017 | -1,740.00 |
| Sep 30, 2017 | -1,167.00 |
| Jun 30, 2017 | -893.00 |
| Mar 31, 2017 | -1,467.00 |
| Dec 31, 2016 | -1,211.00 |
| Sep 30, 2016 | -487.00 |
| Jun 30, 2016 | -2,094.00 |
| Mar 31, 2016 | 3,898.00 |
| Dec 31, 2015 | 520.00 |
| Sep 30, 2015 | -1,609.00 |
| Jun 30, 2015 | -950.00 |